Effects of Omalizumab on FcεRI and IgE Expression in Lesional Skin of Bullous Pemphigoid

Recent studies suggest an important role of immunoglobulin E (IgE) as an alternative pathogenic pathway in the development of bullous pemphigoid (BP), as the most frequent subepidermal blistering disease of the skin Use of IgE targeted therapies, such as omalizumab, has been shown promising in recen...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: S. Morteza Seyed Jafari, Karolina Gadaldi, Laurence Feldmeyer, Nikhil Yawalkar, Luca Borradori, Christoph Schlapbach
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2019-08-01
Seri Bilgileri:Frontiers in Immunology
Konular:
Online Erişim:https://www.frontiersin.org/article/10.3389/fimmu.2019.01919/full